Yehuda Zisapel, Founder and President
Yehuda Zisapel holds an M.Sc. degree in Electronic Engineering from the Haifa Technion (Israel), an MBA from Tel-Aviv University (Israel), and Doctor Honoris Causa from the Technion (Israel). He is the founder and director of the RAD Group, a holding that comprises 22 high-tech companies in computer communication technologies, six of which are publicly held and traded on the NASDAQ, and the chairman of Rad-Ramot Biomedical incubator. He has served as President of Neurim Pharmaceuticals since it commenced active operations in 1992.

Nava Zisapel, Founder and Chief Scientific Officer
Nava Zisapel holds a B.Sc. in Chemistry, an M. Sc. in Biochemistry, and a Ph.D. in Biochemistry from Tel-Aviv University (Israel). She is a full professor at Tel-Aviv University with a specialization in Neuro-biochemistry and the incumbent of the Michael Gluck Chair in Neuropharmacology and ALS Research, USA. Nava Zisapel has authored with her students and collaborator scientists over 160 original research publications in peer-reviewed journals.

Yossi Elihav, Chief Financial Officer
Yossi Elihav holds a B.A. in Accounting and Economics from the Tel Aviv University (Israel). He is a Certified Public Accountant and a member of the Institute of Certified Public Accountants in Israel. Since 1998 he has been the chief financial adviser for the RAD-Bynet Group. Before joining the Group he was a partner in the firm serving as independent public accountants for the companies in the Group. In both positions he managed several IPOs on the NASDAQ. He has served Neurim in a financial capacity since the founding of the company.

Francesca Stingele, Managing Director, Neurim SA
Francesca Stingele holds a Diploma degree in Microbiology and a Ph.D. degree in Molecular Biology from the Technical University in Munich (Germany) and an MBA degree from the University of Geneva. She established a thorough scientific background during two sabbatical stays in the US (University of Arizona, Harvard Medical School) and gained international R&D industry experience at Nestlé where she worked for 8 years. Before joining Neurim she was Group Leader in Glycobiology at the Nestlé Research Center, in the field of infant, clinical and functional nutrition. Francesca joined Neurim in 2001 as Director for Business Development and is since 2003 responsible for the Swiss commercial subsidiary, mainly dealing with the business in the EU.